Equity

BMEZ

BlackRock Health Sciences Trust II

Overview

Loading

Performance

Performance

Performance data is not currently available

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.


Returns are shown net of advisory fees paid by the fund and net of the fund’s operating fees and expenses. Investors who purchase shares of the fund through an investment adviser or other financial professional may separately pay a fee to that service provider. Past performance is not indicative of future results.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be found in the Performance section.

Growth of Hypothetical $10,000 The growth of hypothetical $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

Performance chart data not available for display.
View full chart

Distributions

Interactive chart displaying fund performance. Javascript is required.

View full chart

Key Facts

Key Facts

Net Assets as of Sep 25, 2020 $2,892,763,206
Size of Fund (Millions) as of Sep 25, 2020 $2,892.8 M
Share Class launch date Jan 29, 2020
Exchange New York Stock Exchange Inc.
Asset Class Equity
Morningstar Category Health
Lipper Classification -
CUSIP 09260E105
Management Fee Contractual management fee as percentage of managed assets. as of Jan 31, 2020 1.25%
Gross Expense Ratio as of Jan 31, 2020 1.30%
Shares Outstanding as of Sep 25, 2020 112,669,825
Number of Holdings as of Aug 31, 2020 172
Managed Assets as of Sep 25, 2020 $2,892,763,206.28

Ratings

Holdings

Holdings

as of Aug 31, 2020
Name Weight (%)
GENMAB A/S 3.76
OAK STREET HEALTH INC. 2.79
SEATTLE GENETICS INC 2.74
TELEFLEX INCORPORATED 1.96
AMEDISYS INC 1.93
Name Weight (%)
INTUITIVE SURGICAL INC 1.88
BAXTER INTERNATIONAL INC 1.88
MASIMO CORPORATION 1.84
LHC GROUP INC 1.78
UCB SA 1.60

Exposure Breakdowns

Exposure Breakdowns

as of Aug 31, 2020

% of Market Value

Type Fund
as of Aug 31, 2020

% of Market Value

Type Fund
as of Aug 31, 2020

% of Market Value

Type Fund
as of Aug 31, 2020

% of Market Value

Type Fund
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Erin Xie
Head of the Health Sciences team
Kyle McClements
Kyle McClements
Christopher Accettella
Christopher Accettella
Xiang Liu
BlackRock Health Sciences Team
Jeffrey Lee
BlackRock Health Sciences Team
Portfolio Manager

Literature

Literature